Who are InMed Pharmaceuticals' key executives?
InMed Pharmaceuticals' management team includes the following people: Mr. Eric A. Adams , Pres, CEO & Director (Age 56) Mr. Bruce S. Colwill C.A...
Who are some of InMed Pharmaceuticals' key competitors?
Some companies that are related to InMed Pharmaceuticals include 3SBio (TRSBF) , 45525 (CUR.TO) (CUR) , Abattis Bioceuticals (ATTBF) , Abcam (A...
What is InMed Pharmaceuticals' stock symbol?
InMed Pharmaceuticals trades on the OTCMKTS under the ticker symbol "IMLFF."
How do I buy shares of InMed Pharmaceuticals?
Shares of IMLFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
How many employees does InMed Pharmaceuticals have?
InMed Pharmaceuticals employs 4 workers across the globe.
What is InMed Pharmaceuticals' official website?
The official website for InMed Pharmaceuticals is www.inmedpharma.com .
How can I contact InMed Pharmaceuticals?
The company can be reached via phone at (604) 669-7207 .
InMed Pharmaceuticals (OTCMKTS:IMLFF) Price Target and Consensus Rating
Analyst Price Target Consensus
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Ratings By Month
Sign-up to receive the latest news and ratings for IMLFF and its competitors with MarketBeat's FREE daily newsletter.
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
InMed Pharmaceuticals (OTCMKTS:IMLFF) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
How do I buy InMed Pharmaceuticals Inc (IMLFF) stock?
MarketBeat users like InMed Pharmaceuticals stock more than the stock of other Health Technology companies. 75.71% of MarketBeat users gave InMed Pharmaceuticals an outperform vote while health technology companies recieve an average of 56.25% outperform votes by MarketBeat users.
When is InMed Pharmaceuticals Inc (OTC:IMLFF) reporting earnings?
You can purchase shares of InMed Pharmaceuticals Inc ( OTC: IMLFF) through any online brokerage.
What sector and industry does InMed Pharmaceuticals Inc (IMLFF) operate in?
InMed Pharmaceuticals Inc’s Q4 earnings are confirmed for after-market on September 7, 2021.
